These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11439321)

  • 21. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects.
    Latif F; Tandon S; Obeleniene R; Hankins SR; Berlowitz MS; Ennezat PV; Le Jemtel TH
    J Card Fail; 2001 Sep; 7(3):265-8. PubMed ID: 11561228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valsartan reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension.
    Li QZ; Deng Q; Li JQ; Yi GH; Zhao SP
    Clin Chim Acta; 2005 May; 355(1-2):131-6. PubMed ID: 15820487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
    Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
    Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
    Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.
    Iwanaga T; Sato M; Maeda T; Ogihara T; Tamai I
    J Pharmacol Exp Ther; 2007 Jan; 320(1):211-7. PubMed ID: 17043154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.
    Daneshtalab N; Lewanczuk RZ; Russell A; Jamali F
    J Clin Pharmacol; 2004 Mar; 44(3):245-52. PubMed ID: 14973301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.
    Esnault VL; Ekhlas A; Delcroix C; Moutel MG; Nguyen JM
    J Am Soc Nephrol; 2005 Feb; 16(2):474-81. PubMed ID: 15615822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U; Böhm M
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute renal failure and hypertension].
    Bellido D; Sánchez de la Nieta MD; Vozmediano C; Oteros R; Zarca MA; Nieto J; Rivera F
    Nefrologia; 2005; 25(5):563-7. PubMed ID: 16392308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of valsartan on hepatic stellate cell proliferation and collagen synthesis].
    Shen FJ; Tang SZ; Wang P; Ying CH; Li Q; Jia JD; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):561-2. PubMed ID: 15387916
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.
    Willemsen JM; Westerink JW; Dallinga-Thie GM; van Zonneveld AJ; Gaillard CA; Rabelink TJ; de Koning EJ
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):6-12. PubMed ID: 17261957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Added VALUE of an ancillary study on ambulatory blood pressure monitoring.
    Staessen JA; Hansen TW; Birkenhäger WH
    J Hypertens; 2007 Mar; 25(3):513-5. PubMed ID: 17278965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.